QSI icon

Quantum-Si Incorporated

1.95 USD
-0.08
3.94%
At close Feb 14, 4:00 PM EST
After hours
1.97
+0.02
1.03%
1 day
-3.94%
5 days
-7.14%
1 month
-3.94%
3 months
150.22%
6 months
121.44%
Year to date
-54.23%
1 year
17.47%
5 years
-80.00%
10 years
-80.00%
 

About: Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.

Employees: 165

0
Funds holding %
of 6,831 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

1,825% more call options, than puts

Call options by funds: $308K | Put options by funds: $16K

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

9% more funds holding

Funds holding: 97 [Q2] → 106 (+9) [Q3]

1.57% less ownership

Funds ownership: 44.07% [Q2] → 42.5% (-1.57%) [Q3]

18% less capital invested

Capital invested by funds: $56.2M [Q2] → $45.9M (-$10.4M) [Q3]

30% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 33

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$3.75
92%
upside
Avg. target
$4.63
137%
upside
High target
$5.50
182%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Alliance Global Partners
Scott Henry
25% 1-year accuracy
1 / 4 met price target
92%upside
$3.75
Buy
Initiated
7 Feb 2025
HC Wainwright & Co.
Swayampakula Ramakanth
33% 1-year accuracy
65 / 195 met price target
182%upside
$5.50
Buy
Reiterated
14 Jan 2025

Financial journalist opinion

Based on 5 articles about QSI published over the past 30 days

Neutral
Business Wire
3 days ago
Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025.
Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025
Neutral
Business Wire
4 days ago
Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025.
Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
Neutral
Business Wire
1 week ago
Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies.
Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies
Neutral
Business Wire
2 weeks ago
Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument.
Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument
Neutral
Business Wire
3 weeks ago
Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK.
Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK
Neutral
Business Wire
1 month ago
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neutral
Business Wire
1 month ago
Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics.
Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics
Neutral
Business Wire
1 month ago
Quantum-Si's New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si's New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics.
Quantum-Si's New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics
Positive
Benzinga
1 month ago
Quantum-Si's 327% Rally In Six Months: Is Nvidia The Catalyst For More Gains?
Quantum-Si Inc. QSI is stealing the biotech spotlight with a jaw-dropping 327% surge over the past six months. The proteomics pioneer's stock now sits at $4.10, boasting a strong bullish trend and catching investors' attention.
Quantum-Si's 327% Rally In Six Months: Is Nvidia The Catalyst For More Gains?
Neutral
Business Wire
1 month ago
Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules.
Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock
Charts implemented using Lightweight Charts™